Anesthetics and Cerebral Blood Flow

CBF & CMRO2 Physiology - Brain's Vital Supply

• CBF (Cerebral Blood Flow):
  • Normal: 50 mL/100g/min (15% CO).
  • Autoregulation: MAP 50-150 mmHg.
  • $PaCO_2$: Main driver; CBF ↑ 1-2 mL/100g/min per 1 mmHg $PaCO_2$ ↑ (range 20-80 mmHg).
  • $PaO_2$: CBF ↑ if $PaO_2$ < 50 mmHg.
  • Temp: CBF & CMRO2 ↓ 7% per 1°C ↓.
• CPP (Cerebral Perfusion Pressure):
  • Formula: $CPP = MAP - ICP$.
  • Normal: 60-80 mmHg; Target >70 mmHg (TBI).
• CMRO2 (Cerebral Metabolic Rate of O2):
  • Normal: 3.0-3.8 mL/100g/min.
  • Coupling: CBF matches CMRO2.

⭐ Volatile anesthetics (>1 MAC), head trauma, and tumors can impair/abolish CBF autoregulation.

IV Anesthetics & CBF - Vein Agents & Vessels

Most intravenous (IV) anesthetics, with the notable exception of Ketamine, beneficially decrease Cerebral Blood Flow (CBF) and Cerebral Metabolic Rate of Oxygen (CMRO2). This maintains flow-metabolism coupling and typically leads to reduced Intracranial Pressure (ICP).

Inhaled Anesthetics & CBF - Gas Effects on Brain

• All volatile anesthetics:
  • Cause dose-dependent cerebral vasodilation (↑ CBF).
  • Decrease cerebral metabolic rate for oxygen (↓ CMRO2).
  • Result in uncoupling: ↑ CBF despite ↓ CMRO2 (luxury perfusion).
  • Impair cerebral autoregulation dose-dependently.
• Agent Variations & Key Effects:
  • Halothane: Strongest ↑ CBF; significant ↓ CMRO2.
  • Isoflurane, Sevoflurane, Desflurane:
    • Mild ↑ CBF at < 1 MAC.
    • Significant ↑ CBF at > 1 MAC.
    • Desflurane: Rapid ↑ in concentration may cause sympathetic surge (↑ HR, BP).
  • Nitrous Oxide (N2O):
    • Alone: ↑ CBF and ↑ CMRO2 (unique among anesthetics).
    • With volatile agents: Potentiates their CBF ↑ effects.
• Mechanism of Vasodilation: Primarily direct effects on cerebral vessels (e.g., modulation of NO pathway, K+ channels).
• Clinical Impact:
  • Potential for ↑ Intracranial Pressure (ICP), especially with low intracranial compliance.
  • Hyperventilation (to PaCO2 25-30 mmHg) can temporarily attenuate ↑ CBF.

⭐ Volatile anesthetics cause uncoupling of cerebral metabolism and blood flow: CMRO2 decreases while CBF increases, particularly prominent at concentrations > 1 MAC (termed "luxury perfusion").

Clinical Management & CBF - Neuro Anesthesia Tactics

• Goals: Maintain CPP ($CPP = MAP - ICP$; target >60-70 mmHg), control ICP, optimize cerebral O2 delivery.
• ↑ICP Tactics:
  • Hyperventilation (PaCO2 28-32 mmHg): rapid, transient ↓ICP.
  • Osmotic agents (Mannitol 0.25-1 g/kg IV).
  • Sedation: IV anesthetics (Propofol, Barbiturates) ↓CMRO2, ↓CBF, ↓ICP.
• Anesthetic Choices & CBF:

*   ⭐ > TBI: Target CPP **60-70** mmHg. Aggressive CPP >**70** mmHg using fluids/pressors may increase ARDS risk.

High‑Yield Points - ⚡ Biggest Takeaways

• Volatile anesthetics (e.g., Isoflurane) cause dose-dependent ↑ CBF and ↓ CMRO2 (uncoupling).
• Halothane is the most potent cerebral vasodilator among volatile agents.
• IV agents like Propofol, Barbiturates, Etomidate ↓ CBF & ↓ CMRO2 (neuroprotective coupling).
• Ketamine ↑ CBF & ↑ CMRO2; generally avoided with ↑ Intracranial Pressure (ICP).
• Nitrous oxide (N2O) can ↑ CBF and may ↑ CMRO2.
• Opioids: Minimal direct CBF effect; risk ↑ CBF via respiratory depression & hypercapnia.
• Volatiles at >1 MAC can impair cerebral autoregulation significantly.